Cipla Limited — Updates, 17-04-2026: General Updates
17-04-2026 | 04:32 pm
17-04-2026 | 04:32 pm
Cipla's Goa plant received two USFDA Form 483 observations after an inspection. The company is committed to addressing these promptly, which is crucial for future drug approvals and operational continuity.
No comments yet. Be the first to comment!
